Article Information
History
- November 29, 2021.
Article Versions
- Version 1 (July 14, 2021 - 13:09).
- Version 2 (November 27, 2021 - 13:49).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Wadim Koslow1,
- Martin J. Kühn1,2,
- Sebastian Binder2,
- Margrit Klitz1,
- Daniel Abele1,
- Achim Basermann1,* and
- Michael Meyer-Hermann2,*
- 1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
- 2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
- ↵*Shared corresponding authors in alphabetical order: achim.basermann{at}dlr.de, mmh{at}theoretical-biology.de
Posted November 29, 2021.
Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
